Nyckeltal för: QuiaPEG Pharmaceuticals

Antal månader som rapporten avserQ2 (3 mån)Q3 (3 mån)Q4 (3 mån)HelårQ1 (3 mån)Q2 (3 mån)Q3 (3 mån)Helår
Totala intäkter (Mkr)3.063.757.4014.402.703.313.331.99
Rörelseresultat (Mkr)0.39- 0.26-0.400.90-0.710.02-0.05-0.96
Resultat före skatt (Mkr)---0.90---9.60
Nettoresultat (Mkr)0.33- 0.18-0.500.60-0.450.030.159.60
Vinst per aktie (kr)0.16- 0.52-0.27-
Utdelning/aktie kronor (kr)--------
Eget kapital (Mkr)--6.926.92---18.44
Anläggningstillgångar (Mkr)--2.172.17---2.50
Immateriella anläggningstillgå (Mkr)--------
Omsättningstillgångar (Mkr)--6.716.71---19.59
Summa tillgångar (Mkr)--8.888.88---22.09
Långfristiga skulder inklusive (Mkr)--0.290.29----
Kortfristiga skulder (Mkr)--1.671.67---3.65
Antal aktier (st)2 118 7002 118 7002 118 7002 118 7002 123 7002 233 7002 785 0022 785 002

Innehållet på denna sida leveras av Inquiry Financials och skall läsas i enlighet med nedan citat:

© 2015 Inquiry Financial. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Inquiry Financial and its content providers; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; (5) are not warranted to be complete, accurate or timely; and (6) may be drawn from reports published on various dates. Inquiry Financial is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

Den som har synpunkter på nyckeltalen eller vill ha ytterligare data ombeds att kontakta Inquiry Financial Europe AB, se kontakuppgifter på